Report comparison
Compare up to four published reports side by side.
| Field | Global Immunoassay Market Analysis and Forecast 2026-2031 |
|---|---|
| Publisher | Market Research IQ |
| Price | $2,449 |
| Pages | 157 |
| Base year | 2021 |
| Forecast | 2026-2031 |
| Regions | The regional landscape indicates that North America will maintain its leadership position throughout the forecast period, while Asia-Pacific demonstrates significant growth potential due to scaling demand from emerging economies. Europe holds a steady market share, supported by stringent regulatory frameworks guiding healthcare standards. Latin America and the Middle East & Africa are predicted to witness slower growth due to various economic and infrastructural challenges. Regional market value outlook Region Base year value (USD Billion) Forecast year value (USD Billion) North America 450 770 Europe 300 420 Asia-Pacific 200 440 Latin America 20 30 Middle East & Africa 15 30 |
| Segments | The immunoassay market can be segmented by type, application, end user, and distribution channel. Key types include enzyme-linked immunosorbent assays (ELISA), rapid tests, and multiplex assays. Applications range from disease diagnosis to therapeutic drug monitoring, with end users including hospitals, clinics, and laboratories. Segment market mix Group Lead segment Share (%) Growth signal Insight By Type Enzyme-linked immunosorbent assay (ELISA) 45 Strong growth expected due to increased ch ELISAs are favored for their sensitivity and adaptability. By Application Hospitals 60 Hospital sector remains primary user Investment in immunoassays is prioritized by advanced healthcare networks. By End User Hospitals 23 active buyer group Hospitals drive demand through recurring procurement, modernization, and performance improvement needs. By Distribution Direct sales 70 Stable growth as providers opt for reliabi Direct sales ensure consistent supply and availability. |
| Rating | New |
| Reviews | 0 |